Alnajashi, Hind. “Rituximab As an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review”. Journal of Contemporary Medical Sciences, vol. 11, no. 3, June 2025, doi:10.22317/jcms.v11i3.1892.